Magdalena Skorzewska

Lublin, LU 20059, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Targeted Anti-TF Antibody-Drug Conjugates in Advanced Cervical Cancer-Tisotumab Vedotin-Systematic Review.

Targeted Anti-TF Antibody-Drug Conjugates in Advanced Cervical Cancer-Tisotumab Vedotin-Systematic Review.

Journal: Cancers
Published: July 08, 2026

Enfortumab Vedotin in Advanced or Metastatic Urothelial Carcinoma: A Systematic Review of Efficacy, Safety, and Clinical Perspectives.

Enfortumab Vedotin in Advanced or Metastatic Urothelial Carcinoma: A Systematic Review of Efficacy, Safety, and Clinical Perspectives.

Journal: Cancers
Published: June 23, 2026

Targeting KRASG12C in non-small cell lung cancer: evidence from randomized clinical trials and future therapeutic strategies.

Targeting KRASG12C in non-small cell lung cancer: evidence from randomized clinical trials and future therapeutic strategies.

Journal: Frontiers in oncology
Published: June 22, 2026

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Journal: Current oncology reports
Published: May 25, 2026

Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review.

Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review.

Journal: Frontiers in immunology
Published: April 30, 2026

PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.

PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.

Journal: Oncology reviews
Published: March 19, 2026

Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report.

Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report.

Journal: Frontiers in oncology
Published: March 11, 2026

Sacituzumab govitecan as a therapeutic breakthrough in the treatment of triple-negative breast cancer: a systematic review of clinical trials.

Sacituzumab govitecan as a therapeutic breakthrough in the treatment of triple-negative breast cancer: a systematic review of clinical trials.

Journal: Frontiers in immunology
Published: August 04, 2025

A Step Toward a Global Consensus on Gastric Cancer Resectability Integrating Artificial Intelligence-Based Consensus Modelling.

A Step Toward a Global Consensus on Gastric Cancer Resectability Integrating Artificial Intelligence-Based Consensus Modelling.

Journal: Cancers
Published: July 22, 2025

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Journal: ImmunoTargets and therapy
Published: June 20, 2025

The association between age and lymph node status among patients with breast cancer after neoadjuvant chemotherapy: Eastern European population-based retrospective cohort study.

The association between age and lymph node status among patients with breast cancer after neoadjuvant chemotherapy: Eastern European population-based retrospective cohort study.

Journal: Journal of cancer research and clinical oncology
Published: May 27, 2025

Risk stratification for postoperative complications after CRS and HIPEC in recurrent ovarian cancer patients: a comparative analysis of logistic regression and machine learning models.

Risk stratification for postoperative complications after CRS and HIPEC in recurrent ovarian cancer patients: a comparative analysis of logistic regression and machine learning models.

Journal: Scientific reports
Published: May 13, 2025
Showing 1-12 of 47

Last Updated: 09/26/2026